Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Semler Scientific® Reports Second Quarter 2024 Financial Results and Additional Bitcoin Purchases

      (PRNewsfoto/Semler Scientific, Inc.)

      News provided by

      Semler Scientific, Inc.

      Aug 05, 2024, 16:01 ET

      Share this article

      Share this article


      SANTA CLARA, Calif., Aug. 5, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the second quarter ended June 30, 2024. In addition, the Company announced the purchase of an additional 101 bitcoins for an aggregate amount of $6.0 million. Since announcing the adoption of a bitcoin treasury strategy on May 28, 2024, the Company has purchased 929 bitcoins for a total of $63.0 million.

      "We are pleased to report strong income from operations of $5.4 million in the second quarter," said Doug Murphy-Chutorian, MD, chief executive officer of Semler Scientific. "We remain laser focused on acquiring and holding bitcoin, while supporting and expanding our healthcare business."

      "We are very encouraged by the strong positive reaction to our recent announcement of a bitcoin treasury strategy," said Eric Semler, chairman of Semler Scientific. "We continue to firmly believe that bitcoin is a compelling investment and plan on acquiring additional bitcoins with our cash from operations, as well as with cash generated from the sale of securities under our $150.0 million shelf registration statement, once effective."

      FINANCIAL RESULTS

      For the second quarter ended June 30, 2024, compared to the corresponding period of 2023, Semler Scientific reported:

      • Revenues of $14.5 million, a decrease of $4.1 million, or 22%, compared to $18.6 million.
      • Cost of revenues of $1.3 million, an increase of $0.1 million, or 3%, compared to $1.2 million
      • Total operating expenses, which include cost of revenues, of $9.1 million, a decrease of $2.3 million, or 20%, compared to $11.4 million.
      • Income from operations of $5.4 million, a decrease of $1.8 million, or 25%, compared to $7.2 million.
      • Pre-tax net income of $1.1 million (which includes the change in fair value on our bitcoin holdings of negative $5.1 million), a decrease of $6.6 million, or 85%, compared to $7.7 million.
      • Income tax expense of $1.1 million, or an effective tax rate of 99%, compared to $1.8 million, or an effective tax rate of 23%.
      • Net income of $11 thousand, or breakeven, a decrease of $5.9 million, or 100%, compared to net income of $5.9 million, or $0.88 per basic share and $0.75 per diluted share.

      Semler Scientific's three largest customers (including their affiliates) comprised 44%, 27% and 11% of second quarter 2024 revenues, respectively, and its two largest customers comprised 37% and 34% of second quarter 2023 revenues, respectively.

      BITCOIN HOLDINGS

      On May 28, 2024, Semler Scientific announced the initial purchase of 581 bitcoins for an aggregate amount of $40.0 million. On June 6, 2024, the Company announced the purchase of an additional 247 bitcoins for an aggregate amount of $17.0 million. On June 28, 2024, the Company purchased an additional 49 bitcoins for an aggregate cost of $3.0 million. As of June 30, 2024, the Company held 877 bitcoins with a fair value of $54.9 million, which reflects a cumulative reduction in fair value of $5.1 million.

      Subsequently through August 5, 2024, the Company has purchased an additional 52 bitcoins for an aggregate cost of $3.0 million. Semler Scientific's total holdings as of August 5, 2024 are 929 bitcoins for an aggregate purchase amount of $63.0 million. All purchase amounts include fees and expenses.

      Notice of Conference Call

      Semler Scientific will host a conference call today at 4:30 p.m. ET. The call will address results of the second quarter ended June 30, 2024, as well as provide a business update on Semler Scientific's strategies for the near-term future. Questions can be submitted prior to the start of the call to [email protected].

      Participants are encouraged to pre-register for the conference call using the following link: https://dpregister.com/sreg/10190580/fcfdde76dc. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or who are unable to pre-register may dial in by calling:

      Domestic callers: (833) 816‑1161
      International callers: (412) 317‑0717

      Please specify to the operator that you would like to join the "Semler Scientific Call." The conference call will be archived on Semler Scientific's website at www.semlerscientific.com.

      Semler Scientific, Inc.

      Condensed Statements of Income

      Unaudited

      (In thousands of U.S. Dollars, except share and per share data)




      For the three months ended June 30, 


      For the six months ended June 30, 



      2024


      2023


      2024


      2023














      Revenues


      $

      14,465


      $

      18,605


      $

      30,368


      $

      36,811

      Operating expenses:













      Cost of revenues



      1,255



      1,219



      2,501



      2,488

      Engineering and product development



      1,440



      1,762



      2,578



      3,392

      Sales and marketing



      3,456



      4,985



      7,131



      10,177

      General and administrative



      2,964



      3,459



      5,832



      7,318

       Total operating expenses



      9,115



      11,425



      18,042



      23,375

      Income from operations



      5,350



      7,180



      12,326



      13,436

      Interest and dividend income



      714



      597



      1,534



      1,080

      Change in fair value of notes held for investment



      128



      (111)



      128



      (217)

      Change in fair value of digital assets



      (5,055)



      —



      (5,055)



      —

       Other (expense) income, net



      (4,213)



      486



      (3,393)



      863

      Pre-tax income



      1,137



      7,666



      8,933



      14,299

      Income tax provision



      1,126



      1,787



      2,849



      3,451

      Net income


      $

      11


      $

      5,879


      $

      6,084


      $

      10,848

      Net income per share, basic


      $

      0.00


      $

      0.88


      $

      0.88


      $

      1.62

      Weighted average number of shares used in computing basic net
      income per share



      6,944,664



      6,707,341



      6,918,709



      6,704,306

      Net income per share, diluted


      $

      0.00


      $

      0.75


      $

      0.78


      $

      1.38

      Weighted average number of shares used in computing diluted
      net income per share



      7,795,149



      7,867,001



      7,789,101



      7,887,584

      Semler Scientific, Inc.

      Condensed Balance Sheets

      (In thousands of U.S. Dollars, except share and per share data)




      June 30, 


      December 31, 



      2024


      2023



      Unaudited




      Assets







      Current Assets:







      Cash and cash equivalents


      $

      7,332


      $

      57,200

      Restricted cash



      132



      132

      Trade accounts receivable, net of allowance for credit losses of $243 and $287, respectively



      7,470



      6,125

      Short-term notes held for investments



      6,100



      —

      Inventory, net



      385



      445

      Prepaid expenses and other current assets



      2,271



      2,042

      Total current assets



      23,690



      65,944

      Assets for lease, net



      1,768



      2,285

      Property and equipment, net



      620



      720

      Long-term investments



      512



      512

      Notes held for investment



      —



      5,372

      Intangible digital assets



      54,945



      —

      Other non-current assets



      127



      270

      Deferred tax assets, net of valuation allowance of $1,207 and $0, respectively



      3,124



      2,962

      Total assets


      $

      84,786


      $

      78,065








      Liabilities and Stockholders' Equity







       Current liabilities:







        Accounts payable


      $

      227


      $

      402

        Accrued expenses



      5,086



      4,502

        Deferred revenue



      840



      1,120

        Other short-term liabilities



      211



      176

        Total current liabilities



      6,364



      6,200








      Long-term liabilities:







      Other long-term liabilities



      24



      70

      Total long-term liabilities



      24



      70

      Commitments and contingencies (Note 15)







      Stockholders' equity:







      Common stock, $0.001 par value; 50,000,000 shares authorized; 7,202,146 and 7,099,441 shares
      issued, and 6,987,724 and 6,885,019 shares outstanding (treasury shares of 214,422 and
      214,422), respectively



      7



      7

      Additional paid-in capital



      12,504



      11,985

      Retained earnings



      65,887



      59,803

      Total stockholders' equity



      78,398



      71,795








      Total liabilities and stockholders' equity


      $

      84,786


      $

      78,065

      Semler Scientific, Inc.

      Condensed Statements of Cash Flows

      Unaudited

      (In thousands of U.S. Dollars)




      Six months ended June 30,



      2024


      2023

      CASH FLOWS FROM OPERATING ACTIVITIES:







      Net income


      $

      6,084


      $

      10,848








      Reconciliation of Net Income to Net Cash Provided by Operating Activities:







      Depreciation



      346



      279

      Deferred tax expense



      (163)



      (207)

      Loss on disposal of assets for lease



      319



      114

      Gain on short-term investments



      —



      (237)

      Allowance for credit losses



      (44)



      92

      Change in fair value of notes held for investment



      (128)



      217

      Change in fair value of digital assets



      5,055



      —

      Stock-based compensation



      295



      860

      Changes in Operating Assets and Liabilities:







      Trade accounts receivable



      (1,292)



      (2,240)

      Inventory



      60



      (7)

      Prepaid expenses and other current assets



      (135)



      (950)

      Other non-current assets



      43



      106

      Accounts payable



      (175)



      (326)

      Accrued expenses



      584



      3,495

      Other current and non-current liabilities



      (291)



      13

      Net Cash Provided by Operating Activities



      10,558



      12,057








      CASH FLOWS FROM INVESTING ACTIVITIES:







      Additions to property and equipment



      (48)



      (260)

      Purchase of notes held for investment



      (500)



      (500)

      Purchase of digital assets



      (60,000)



      —

      Proceeds from maturities of short-term investments



      —



      57,707

      Purchase of short-term investments



      —



      (49,728)

      Purchase of assets for lease






      (674)

      Net Cash (Used in) Provided by Investing Activities



      (60,548)



      6,545








      CASH FLOWS FROM FINANCING ACTIVITIES:







      Repurchase of warrants



      —



      (1,949)

      Taxes paid related to net settlement of equity awards



      (45)



      (172)

      Stock issuance expenses



      (102)



      —

      Proceeds from exercise of stock options



      269



      —

      Net Cash Provided by (Used in) Financing Activities



      122



      (2,121)

      (DECREASE) INCREASE  IN CASH



      (49,868)



      16,481

      CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD



      57,332



      23,014

      CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD


      $

      7,464


      $

      39,495

      Semler Scientific, Inc.

      Digital Assets- Additional Information

      Rollforward of bitcoin holdings

      Unaudited



      Source of
      Capital
      Used to
      Purchase
      Bitcoin


      Digital Assets
      at Cost
      (in
      thousands)


      Change in
      fair Value
      (in
      thousands)


      Digital Assets
      at Fair Value
      (in
      thousands)


      Approximate
      Number of
      Bitcoin Held


      Approximate
      Average
      Purchase
      Price Per
      Bitcoin

      Balance as of March 31, 2024



      $

      —


      $

      —


      $

      —


      —


      $

      —

      Digital assets purchased

      (a)



      60,000



      —



      60,000


      877



      68,436

      Change in fair value of the digital assets




      —



      (5,055)



      (5,055)


      —



      —

      Balance as of June 30, 2024



      $

      60,000


      $

      (5,055)


      $

      54,945


      877


      $

      68,436



       (a)

      Cash from operations

      About Semler Scientific, Inc.:

      Semler Scientific, Inc. is a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases. Its flagship product, QuantaFlo®, which is patented and cleared by the U.S. Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and Semler Scientific is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). Semler Scientific also invests in bitcoin and has adopted bitcoin as its primary treasury asset. Additional information about Semler Scientific can be found at www.semlerscientific.com.

      Forward-Looking Statements

      This press release contains "forward-looking" statements. Such statements can be identified by, among other things, the use of forward-looking language such as the words "believe," "goal," "may," "will," "intend," "expect," "anticipate," "estimate," "project," "would," "could" or words with similar meaning or the negatives of these terms or by the discussion of strategy or intentions. The forward-looking statements in this release include express or implied statements regarding expansion of the healthcare business; seeking a new 510(k) clearance for QuantaFlo with expanded indications for use; purchase of additional bitcoin; value of bitcoin and ability to execute on the bitcoin treasury strategy; among others. Such forward-looking statements are subject to a number of risks and uncertainties that could cause Semler Scientific's actual results to differ materially from those discussed here, such as such as risks inherent with investing in bitcoin, including bitcoin's volatility; risk of implementing a new bitcoin treasury strategy; risk that insurance plans and other customers will not continue to license its cardiovascular testing products; risk of changes in the reimbursement landscape for its customers including related to the Centers for Medicare and Medicaid Services (CMS) rate announcement; risk of obtaining a new 510(k) clearance for expanded indications; along with those other risk factors detailed in Semler Scientific's filings with the Securities and Exchange Commission. These forward-looking statements involve assumptions, estimates, and uncertainties that reflect current internal projections, expectations or beliefs. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. All forward-looking statements contained in this press release are qualified in their entirety by these cautionary statements and the risk factors described above. Furthermore, all such statements are made as of the date of this release and Semler Scientific assumes no obligation to update or revise these statements unless otherwise required by law.

      No Offer or Solicitation

      This press release does not and shall not constitute an offer to sell or a solicitation of an offer to buy any securities of Semler Scientific, Inc., nor shall there be any offer, solicitation or sale of such securities, in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

      INVESTOR CONTACT:

      Renae Cormier
      Chief Financial Officer
      [email protected] 

      SOURCE Semler Scientific, Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.